LEGN logo

Legend Biotech Corporation (LEGN) EBITDA

Annual EBITDA:

-$286.21M+$135.55M(+32.14%)
December 31, 2024

Summary

  • As of today, LEGN annual EBITDA is -$286.21 million, with the most recent change of +$135.55 million (+32.14%) on December 31, 2024.
  • During the last 3 years, LEGN annual EBITDA has risen by +$93.87 million (+24.70%).
  • LEGN annual EBITDA is now -2144.66% below its all-time high of $14.00 million, reached on December 1, 2017.

Performance

LEGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

Quarterly EBITDA:

-$113.72M-$24.85M(-27.96%)
June 30, 2025

Summary

  • As of today, LEGN quarterly EBITDA is -$113.72 million, with the most recent change of -$24.85 million (-27.96%) on June 30, 2025.
  • Over the past year, LEGN quarterly EBITDA has dropped by -$106.61 million (-1497.89%).
  • LEGN quarterly EBITDA is now -316.78% below its all-time high of $52.46 million, reached on December 31, 2024.

Performance

LEGN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

TTM EBITDA:

-$260.04M-$106.61M(-69.48%)
June 30, 2025

Summary

  • As of today, LEGN TTM EBITDA is -$260.04 million, with the most recent change of -$106.61 million (-69.48%) on June 30, 2025.
  • Over the past year, LEGN TTM EBITDA has dropped by -$17.05 million (-7.01%).
  • LEGN TTM EBITDA is now -2101.52% below its all-time high of -$11.81 million, reached on March 31, 2019.

Performance

LEGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

LEGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+32.1%-1497.9%-7.0%
3Y3 Years+24.7%+40.6%+42.1%
5Y5 Years-117.2%+15.6%+15.4%

LEGN EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+34.9%-316.8%+39.8%-129.8%+47.5%
5Y5-Year-117.2%+34.9%-316.8%+40.6%-129.8%+47.5%
All-TimeAll-Time-2144.7%+34.9%-316.8%+40.6%-2101.5%+47.5%

LEGN EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$113.72M(-28.0%)
-$260.04M(-69.5%)
Mar 2025
-
-$88.87M(-269.4%)
-$153.44M(-35.6%)
Dec 2024
-$286.21M(+32.1%)
$52.46M(+147.7%)
-$113.16M(+62.4%)
Sep 2024
-
-$109.91M(-1444.3%)
-$301.26M(-24.0%)
Jun 2024
-
-$7.12M(+85.4%)
-$243.00M(+42.8%)
Mar 2024
-
-$48.59M(+64.2%)
-$424.79M(+11.1%)
Dec 2023
-$421.76M(+4.1%)
-$135.64M(-162.6%)
-$477.87M(-2.1%)
Sep 2023
-
-$51.65M(+72.7%)
-$467.85M(+5.0%)
Jun 2023
-
-$188.91M(-85.8%)
-$492.64M(+0.5%)
Mar 2023
-
-$101.68M(+19.1%)
-$495.17M(-16.6%)
Dec 2022
-$439.66M(-15.7%)
-$125.61M(-64.3%)
-$424.57M(-5.1%)
Sep 2022
-
-$76.45M(+60.1%)
-$403.96M(+10.1%)
Jun 2022
-
-$191.43M(-515.9%)
-$449.20M(-28.6%)
Mar 2022
-
-$31.08M(+70.4%)
-$349.31M(+15.4%)
DateAnnualQuarterlyTTM
Dec 2021
-$380.08M(-72.5%)
-$105.01M(+13.7%)
-$412.79M(-12.1%)
Sep 2021
-
-$121.69M(-32.9%)
-$368.39M(-17.4%)
Jun 2021
-
-$91.53M(+3.2%)
-$313.67M(+12.1%)
Mar 2021
-
-$94.56M(-56.0%)
-$356.93M(-16.5%)
Dec 2020
-$220.32M(-67.2%)
-$60.61M(+9.5%)
-$306.31M(+0.3%)
Sep 2020
-
-$66.96M(+50.3%)
-$307.30M(-14.6%)
Jun 2020
-
-$134.79M(-206.7%)
-$268.04M(-65.8%)
Mar 2020
-
-$43.95M(+28.7%)
-$161.70M(-24.8%)
Dec 2019
-$131.79M(-858.5%)
-$61.60M(-122.3%)
-$129.57M(-90.6%)
Sep 2019
-
-$27.71M(+2.6%)
-$67.97M(-68.8%)
Jun 2019
-
-$28.45M(-140.8%)
-$40.26M(-240.8%)
Mar 2019
-
-$11.81M
-$11.81M
Dec 2018
-$13.75M(-198.2%)
-
-
Dec 2017
$14.00M
-
-

FAQ

  • What is Legend Biotech Corporation annual EBITDA?
  • What is the all-time high annual EBITDA for Legend Biotech Corporation?
  • What is Legend Biotech Corporation annual EBITDA year-on-year change?
  • What is Legend Biotech Corporation quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Legend Biotech Corporation?
  • What is Legend Biotech Corporation quarterly EBITDA year-on-year change?
  • What is Legend Biotech Corporation TTM EBITDA?
  • What is the all-time high TTM EBITDA for Legend Biotech Corporation?
  • What is Legend Biotech Corporation TTM EBITDA year-on-year change?

What is Legend Biotech Corporation annual EBITDA?

The current annual EBITDA of LEGN is -$286.21M

What is the all-time high annual EBITDA for Legend Biotech Corporation?

Legend Biotech Corporation all-time high annual EBITDA is $14.00M

What is Legend Biotech Corporation annual EBITDA year-on-year change?

Over the past year, LEGN annual EBITDA has changed by +$135.55M (+32.14%)

What is Legend Biotech Corporation quarterly EBITDA?

The current quarterly EBITDA of LEGN is -$113.72M

What is the all-time high quarterly EBITDA for Legend Biotech Corporation?

Legend Biotech Corporation all-time high quarterly EBITDA is $52.46M

What is Legend Biotech Corporation quarterly EBITDA year-on-year change?

Over the past year, LEGN quarterly EBITDA has changed by -$106.61M (-1497.89%)

What is Legend Biotech Corporation TTM EBITDA?

The current TTM EBITDA of LEGN is -$260.04M

What is the all-time high TTM EBITDA for Legend Biotech Corporation?

Legend Biotech Corporation all-time high TTM EBITDA is -$11.81M

What is Legend Biotech Corporation TTM EBITDA year-on-year change?

Over the past year, LEGN TTM EBITDA has changed by -$17.05M (-7.01%)
On this page